Use and outcomes of epoetin alfa and darbepoetin alfa for anemic cancer patients in outpatient community practice settings.

被引：1
|
作者：
Fahrbach, KR
Frame, D
Sercus, B
Schenkel, B
机构：
[1] Metaworks Inc, Res & Stat, Medford, MA USA
[2] Johnson & Johnson Pharmaceut Serv LLC, Hlth Econ & Pricing, Raritan, NJ USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.5588.5588
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5588
引用
收藏
页码：485B / 486B
页数：2
相关论文
共 50 条
  • [1] Utilization trends of epoetin alfa and darbepoetin alfa in adult patients with cancer receiving chemotherapy in community practice settings.
    Coletti, T
    Howell, JB
    Todoroff, K
    Gregory, KL
    Fastenau, JM
    BLOOD, 2004, 104 (11) : 413B - 413B
  • [2] Regarding "randomized comparison of epoetin alfa and darbepoetin alfa in anemic patients with cancer receiving chemotherapy"
    Nowrousian, Mohammad Resa
    ONCOLOGIST, 2006, 11 (05): : 535 - 536
  • [3] Use of darbepoetin alfa and epoetin alfa in clinical practice in patients with cancer-related anemia
    Berger, Arlel
    Edelsberg, John
    Kallich, Joel
    Oster, Gerry
    CLINICAL THERAPEUTICS, 2008, 30 (01) : 206 - 218
  • [4] Regarding "randomized comparison of epoetin alfa and darbepoetin alfa in anemic patients with cancer receiving chemotherapy" - In Reply
    Waltzman, Roger
    ONCOLOGIST, 2006, 11 (05): : 536 - 537
  • [5] Comparison of anemia treatment outcomes in patients with cancer receiving epoetin alfa and darbepoetin alfa.
    Fahrbach, KR
    Frame, D
    Scheye, R
    Fastenau, JM
    Drielick, M
    Piech, CT
    Nalysnyk, L
    BLOOD, 2003, 102 (11) : 510B - 511B
  • [6] Epoetin alfa and darbepoetin alfa anemia treatment outcomes in cancer patients from a VA perspective
    Papatheofanis, FJ
    Fastenau, JM
    Chiang, T
    Piech, CT
    VALUE IN HEALTH, 2004, 7 (03) : 246 - 246
  • [7] Differences in treatment practice, response rates and cost of Epoetin alfa and Darbepoetin alfa treatment for anemic cancer patients: A retrospective analysis from Sweden
    Persson, U
    Borg, S
    Jansson, S
    Ekman, T
    Franksson, L
    Friesland, S
    Larsson, AM
    VALUE IN HEALTH, 2004, 7 (06) : 681 - 681
  • [8] Erythropoietic agents in routine clinical practice: a retrospective observational survey of epoetin alfa, epoetin beta and darbepoetin alfa use in anaemia patients with cancer
    Pujade-Lauraine, Eric
    Richard, Alain J.
    Sapede, Claudine
    ANNALS OF ONCOLOGY, 2004, 15 : 220 - 220
  • [9] Comparative study of epoetin alfa and darbepoetin alfa in hemodialysis patients
    Valdueza, Julio
    Martinez, Noemi
    Martinez, M. Jose
    Montero, Monica
    Alvarez, Juliana
    Siquier, Pedro
    Inaraja, Maria T.
    Castro, Ines
    Pego, Jose M.
    PHARMACY WORLD & SCIENCE, 2007, 29 (05): : 475 - 476
  • [10] Epoetin alfa and darbepoetin alfa dosing patterns in anemic pre-dialysis chronic kidney disease patients
    Mody, S
    Padmanabhan, V
    McKenzie, RS
    Bookhart, B
    VALUE IN HEALTH, 2006, 9 (03) : A96 - A96
12345